EP0873350A4 - Isolated nucleic acid molecule which encodes murine tumor rejection antigen precursor smage-3 - Google Patents

Isolated nucleic acid molecule which encodes murine tumor rejection antigen precursor smage-3

Info

Publication number
EP0873350A4
EP0873350A4 EP96921675A EP96921675A EP0873350A4 EP 0873350 A4 EP0873350 A4 EP 0873350A4 EP 96921675 A EP96921675 A EP 96921675A EP 96921675 A EP96921675 A EP 96921675A EP 0873350 A4 EP0873350 A4 EP 0873350A4
Authority
EP
European Patent Office
Prior art keywords
smage
nucleic acid
acid molecule
isolated nucleic
tumor rejection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96921675A
Other languages
German (de)
French (fr)
Other versions
EP0873350A1 (en
Inventor
Olivier Debacker
Etienne Deplaen
Thierry Boon-Falleur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Ludwig Institute for Cancer Research New York
Original Assignee
Ludwig Institute for Cancer Research Ltd
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, Ludwig Institute for Cancer Research New York filed Critical Ludwig Institute for Cancer Research Ltd
Publication of EP0873350A1 publication Critical patent/EP0873350A1/en
Publication of EP0873350A4 publication Critical patent/EP0873350A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP96921675A 1995-06-29 1996-06-18 Isolated nucleic acid molecule which encodes murine tumor rejection antigen precursor smage-3 Withdrawn EP0873350A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49651795A 1995-06-29 1995-06-29
PCT/US1996/010518 WO1997001574A1 (en) 1995-06-29 1996-06-18 Isolated nucleic acid molecule which encodes murine tumor rejection antigen precursor smage-3
US496517 2000-02-02

Publications (2)

Publication Number Publication Date
EP0873350A1 EP0873350A1 (en) 1998-10-28
EP0873350A4 true EP0873350A4 (en) 1999-06-30

Family

ID=23972981

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96921675A Withdrawn EP0873350A4 (en) 1995-06-29 1996-06-18 Isolated nucleic acid molecule which encodes murine tumor rejection antigen precursor smage-3

Country Status (6)

Country Link
EP (1) EP0873350A4 (en)
JP (1) JPH11508767A (en)
AU (1) AU6283496A (en)
CA (1) CA2224662A1 (en)
WO (1) WO1997001574A1 (en)
ZA (1) ZA965372B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1659178E (en) 1998-02-05 2010-06-28 Glaxosmithkline Biolog Sa A process for the purification or production of a mage protein
EP1986494B2 (en) † 2006-02-23 2023-10-18 Fmc Corporation Stable mixtures of microencapsulated and non-encapsulated pesticides

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994005304A1 (en) * 1992-08-31 1994-03-17 Ludwig Institute For Cancer Research Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342774A (en) * 1991-05-23 1994-08-30 Ludwig Institute For Cancer Research Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994005304A1 (en) * 1992-08-31 1994-03-17 Ludwig Institute For Cancer Research Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BACKER DE O ET AL: "STRUCTURE, CHROMOSOMAL LOCATION, AND EXPRESSION PATTERN OF THREE MOUSE GENES HOMOLOGOUS TO THE HUMAN MAGE GENES", GENOMICS, vol. 28, no. 1, 24 July 1995 (1995-07-24), pages 74 - 83, XP000670311 *
See also references of WO9701574A1 *

Also Published As

Publication number Publication date
JPH11508767A (en) 1999-08-03
AU6283496A (en) 1997-01-30
EP0873350A1 (en) 1998-10-28
WO1997001574A1 (en) 1997-01-16
CA2224662A1 (en) 1997-01-16
ZA965372B (en) 1998-01-16

Similar Documents

Publication Publication Date Title
HK1034611A1 (en) Double ended isolated d.c-d.c converter
ZA9811586B (en) Process for the synthesis of 1,3-diols
EP0598998A3 (en) Humanized antibodies reacting with the ganglioside GM2.
ZA967702B (en) Method for the manufacture of spiral bristles
ZA962280B (en) RAGE tumor rejection antigens
GB9516145D0 (en) Improved chemical synthesis
ZA9710005B (en) New manufacturing process of metoprolol.
AU7689696A (en) Dna sequence encoding the tumor suppressor ing1
EP0569215A3 (en) Clinical chemistry analyser.
HK1008228A1 (en) Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen
ZA975588B (en) Isolated nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof.
ZA989631B (en) Process for the production of N-Butanol.
FI970071A0 (en) Isolated nucleic acid sequence encoding HLA-A2-expressed tumor rejection antigen
ZA961082B (en) DNA sequence.
EP0771358A4 (en) Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof
EP0873350A4 (en) Isolated nucleic acid molecule which encodes murine tumor rejection antigen precursor smage-3
AU4264097A (en) Mage-10 encoding cdna, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof
AU5429896A (en) Rage tumor rejection antigens
HK1027110A1 (en) Production of avermectin compounds.
ZA989338B (en) Process for the synthesis of chloropurine intermediates.
ZA982255B (en) Process for the preparation of arylmalonates.
ZA966452B (en) Process for the preparation of substituted aminocarbonyltriazolinones.
AU1809695A (en) Tumor associated monoclonal antibody 123av16
GB9721432D0 (en) Improved production of antibodies through the use of antigen antibody complexes
IT1284797B1 (en) PROCEDURE FOR THE PRODUCTION OF PYRAZINE COMPOUNDS.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980121

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19990517

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 6C 12N 15/12 A, 6C 07H 21/04 B, 6C 12Q 1/68 B, 6C 12N 1/11 B, 6C 12N 1/13 B, 6C 12N 1/15 B, 6C 12N 1/19 B, 6C 12N 1/21 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19991104